CTRI/2025/03/081740已完成不适用
Dermatological safety of investigational products thorough primary irritation patch tests on healthy human Indian volunteers with sensitive skin.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ITC LIMITED
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Dermatological safety / Irritation potential on skin
研究概览
简要总结
Single application, Semi-occlusive and closed occlusive patch study
Duration of Study:9 days as per BIS standard
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Female and male Asian Indian subjects.
- •Skin is healthy on the studied anatomic unit 3)Subjects who have not participated in a similar investigation in the past eight weeks.
- •Subjects representing sensitive skin type and varied skin type (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination).
排除标准
- •For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.
- •Having eczema, psoriasis, lichen planus, vitiligo etc.
- •in the concerned area.
- •Having healing disorder in the concerned area.
- •Having rhinitis, allergic conjunctivitis, or rhino sinusitis.
- •Having an allergy to perfumes and/or preservatives in cosmetic products.
- •Having an allergy to plaster / adhesives used in plaster.
- •Having a food allergy.
- •Having a cardiovascular pathology that requires beta blocking treatments.
- •Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
- •Taking specific treatment on the back.
- •Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study.
- •Having miliaria (prickly heat) on the back.
- •Presenting too many neavi on the back.
- •Having high pilosity on the back.
结局指标
主要结局
Dermatological safety / Irritation potential on skin
时间窗: Baseline,0 hrs,24 hrs & 7 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Safety evaluation of cosmetic products on human volunteersCTRI/2025/06/089252ITC LIMITED40
已完成
不适用
Primary Irritation Patch Test for assessing dermatological safety of test products on healthy Indian volunteers with normal skin. (Single 24-hour Application).CTRI/2025/04/085059ITC Life Sciences & Technology Centre26
已完成
不适用
Safety assessment of products on skinCTRI/2019/05/019272ITC Life Sciences Technology Centre24
已完成
不适用
Safety assessment of products on skinCTRI/2019/06/019659ITC Life Sciences Technology Centre24
已完成
不适用
Safety assessment of test products on skinCTRI/2022/06/043465ITC LIMITED ITC Life Sciences and Technology Centre24